LIVE

€5.97 ▼−1.82%

/Expedition Base Set/Quilava

Variants

HIGH · Conviction 6/10

Quilava

Expedition Base Set · #91 · Uncommon

Graded

PSA 9€22.32

PSA 10€64.28

Composite

5.6

Verify externally — possibly staleEU 44% below US

Buy range€5.20 – €6.80Good buy

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.6

SCORE / 10

Liquidity

9.6

Scarcity

9.9

Era potential

10.0

Friction

6.8

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 26.02%Total population

PSA 10

128

PSA 9

180

PSA 8

110

Total graded

492

Gem rate 26.02%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

The Expedition Base Set Quilava (#91) currently trades at €6.34 in the raw market. Its 30-day price movement has appreciated (+32.5%). By market value it ranks #98 of 165 in Expedition Base Set — the 40th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated high. Read together, a mid-tier ranking in Expedition Base Set alongside rising 30-day momentum frames where Quilava sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.